Get the Stockscreener App
11.13
0.36%
-0.04
After Hours:
11.13
Enfusion Inc stock is traded at $11.13, with a volume of 601.70K.
It is down -0.36% in the last 24 hours and up +6.30% over the past month.
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.
See More
Previous Close:
$11.17
Open:
$11.2
24h Volume:
601.70K
Relative Volume:
0.86
Market Cap:
$1.06B
Revenue:
$174.54M
Net Income/Loss:
$6.03M
P/E Ratio:
139.12
EPS:
0.08
Net Cash Flow:
$15.96M
1W Performance:
+0.27%
1M Performance:
+6.30%
6M Performance:
+17.03%
1Y Performance:
+38.61%
1-Day Range:
$11.11
$11.20
1-Week Range:
$11.01
$11.20
52-Week Range:
$7.60
$11.38
Enfusion Inc Stock (ENFN) Company Profile
Name
Enfusion Inc
Sector
Industry
Phone
(312) 253-9800
Address
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
Compare ENFN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENFN
Enfusion Inc
|
11.13 | 1.06B | 174.54M | 6.03M | 15.96M | 0.08 |
|
CRM
Salesforce Inc
|
343.57 | 329.64B | 37.19B | 5.94B | 11.87B | 6.08 |
|
SAP
Sap Se Adr
|
279.36 | 325.94B | 36.09B | 2.98B | 7.67B | 2.4878 |
|
NOW
Servicenow Inc
|
1,012.75 | 206.16B | 10.46B | 1.34B | 3.35B | 6.43 |
|
INTU
Intuit Inc
|
604.60 | 168.18B | 16.59B | 2.92B | 5.14B | 10.30 |
|
SHOP
Shopify Inc
|
119.18 | 154.26B | 8.21B | 1.38B | 1.43B | 1.07 |
Enfusion Inc Stock (ENFN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-10-24 | Resumed | Morgan Stanley | Overweight |
| Feb-28-24 | Downgrade | Goldman | Neutral → Sell |
| Jan-30-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-07-23 | Initiated | UBS | Neutral |
| Apr-03-23 | Initiated | Piper Sandler | Neutral |
| Mar-15-23 | Initiated | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-03-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-15-21 | Initiated | BofA Securities | Buy |
| Nov-15-21 | Initiated | Credit Suisse | Neutral |
| Nov-15-21 | Initiated | Goldman | Neutral |
| Nov-15-21 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-21 | Initiated | Piper Sandler | Overweight |
| Nov-15-21 | Initiated | Stifel | Buy |
| Nov-15-21 | Initiated | William Blair | Outperform |
View All
Enfusion Inc Stock (ENFN) Latest News
An Update On The Enfusion Buyout (NYSE:ENFN) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Stockholders to Connect - Markets Insider
Trading (ENFN) With Integrated Risk Controls - Stock Traders Daily
JPMorgan Chase & Co. Grows Holdings in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSEENFN), Intra-Cellular Therapies, Inc. (NasdaqITCI), H&E Equipment Services, Inc. (NasdaqHEES), Shutterstock, Inc. (NYSE - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, HEES, AMPY, TURN on Behalf of Shareholders - The Eastern Progress Online
Clearwater agrees to buy investment management platform Enfusion for $1.5B - MSN
Enfusion (NYSE:ENFN) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – CCNE, ITCI, ENFN, AMPY - GlobeNewswire Inc.
Enfusion director Somers sells $17,237 in stock to cover taxes By Investing.com - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation - Markets Insider
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders - Longview News-Journal
2025-01-16 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation | NYSE:ENFN | Press Release - Stockhouse Publishing
Barclays PLC Boosts Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World
Enfusion, Inc. (NYSE:ENFN) Director Deirdre Somers Sells 1,637 Shares - MarketBeat
Enfusion director Somers sells $17,237 in stock to cover taxes - Investing.com India
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Investors to Reach Out - AccessWire
Analysts Set Enfusion, Inc. (NYSE:ENFN) PT at $10.25 - Defense World
DA Davidson lifts Clearwater stock rating to Buy in light of merger with Enfusion - Investing.com Canada
Clearwater Analytics stock outlook shifts as Enfusion deal sparks mixed market response - Investing.com Canada
2025-01-14 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Investors to Reach Out | NYSE:ENFN | Press Release - Stockhouse Publishing
Enfusion downgraded to Hold from Buy at Stifel - Yahoo Finance
Clearwater Analytics to buy software maker Enfusion for $1.5 billion to drive global expansion - MSN
Clearwater buyout drives Enfusion stock downgrade, says Morgan Stanley By Investing.com - Investing.com Canada
Clearwater buyout drives Enfusion stock downgrade, says Morgan Stanley - Investing.com India
William Blair Downgrades Enfusion (ENFN) - MSN
Clearwater Analytics acquires software maker Enfusion for $1.5 billion to drive global expansion - MSN
Clearwater Analytics to acquire investment management platform Enfusion for $1.5bn - FinTech Futures
Stifel cuts Enfusion stock rating to Hold, lowers price target on acquisition - Investing.com Australia
Enfusion (NYSE:ENFN) Given “Market Perform” Rating at William Blair - Defense World
Clearwater to acquire Enfusion to expand its Investment Management Platform - IBS Intelligence
Clearwater Analytics to acquire Enfusion in $1.5 billion deal - MSN
Clearwater Analytics agrees to by Enfusion for $1.5B - Axios
Clearwater Analytics to build alts platform with Enfusion acquisition - Alternatives Watch
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Enfusion, Inc.ENFN - The Malaysian Reserve
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc.ENFN - Marketscreener.com
Clearwater Analytics to Buy Investment Management SaaS Platform Enfusion for $1.5 Billion - Finovate
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push - MSN
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Enfusion, Inc. - PrimePublishers.com
Clearwater acquires Enfusion in $1.5B financial software deal - SiliconANGLE News
ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm - Business Wire
Enfusion (NYSE:ENFN) Given Market Perform Rating at William Blair - MarketBeat
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders - Stockhouse Publishing
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Me - GuruFocus.com
Enfusion Inc Stock (ENFN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
2.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):